ExoNet Tuned to Gravity Support for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stroke+1 More
ExoNet Tuned to Gravity Support - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new robot device to help people with chronic stroke retrain their movement. The robot will help by compensating for gravity.

Eligible Conditions
  • Stroke
  • Cerebrovascular Accident

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)

Week 9
Upper arm
Box and Blocks
Fugl-Meyer
Wolf Motor Function Test
Week 3
Electromyography using Delsys
Kinect

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Experimental Group: Gravity Compensation
1 of 2
Control Group: No Gravity Compensation
1 of 2
Experimental Treatment
Non-Treatment Group

20 Total Participants · 2 Treatment Groups

Primary Treatment: ExoNet Tuned to Gravity Support · Has Placebo Group · N/A

Experimental Group: Gravity Compensation
Device
Experimental Group · 1 Intervention: ExoNet Tuned to Gravity Support · Intervention Types: Device
Control Group: No Gravity Compensation
Device
ShamComparator Group · 1 Intervention: ExoNet Tuned to Gravity Support · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)

Who is running the clinical trial?

Shirley Ryan AbilityLabLead Sponsor
170 Previous Clinical Trials
13,355 Total Patients Enrolled
63 Trials studying Stroke
5,794 Patients Enrolled for Stroke

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a moderate impairment (Fugl-Meyer score between 15-50).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: October 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.